These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33016074)

  • 1. Optimized Sample Preparation and Data Processing of Data-Independent Acquisition Methods for the Robust Quantification of Trace-Level Host Cell Protein Impurities in Antibody Drug Products.
    Pythoud N; Bons J; Mijola G; Beck A; Cianférani S; Carapito C
    J Proteome Res; 2021 Jan; 20(1):923-931. PubMed ID: 33016074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced mass spectrometry workflows for accurate quantification of trace-level host cell proteins in drug products: Benefits of FAIMS separation and gas-phase fractionation DIA.
    Beaumal C; Beck A; Hernandez-Alba O; Carapito C
    Proteomics; 2023 Aug; 23(16):e2300172. PubMed ID: 37148167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
    Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
    J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated strategy for deep profiling of host cell proteins in downstream processing of therapeutic monoclonal antibodies: Novel approach to isolate and digest host cell proteins.
    Zarei M; Jonveaux J; Razvi A; Jahn M
    Eur J Pharm Biopharm; 2024 Aug; 201():114369. PubMed ID: 38885909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development.
    Huang Y; Molden R; Hu M; Qiu H; Li N
    J Pharm Biomed Anal; 2021 Jun; 200():114069. PubMed ID: 33901758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Host Cell Protein Analysis in Monoclonal Antibody Products through Molecular Weight Cutoff Enrichment.
    Chen IH; Xiao H; Daly T; Li N
    Anal Chem; 2020 Mar; 92(5):3751-3757. PubMed ID: 31999105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved host cell protein analysis in monoclonal antibody products through ProteoMiner.
    Chen IH; Xiao H; Li N
    Anal Biochem; 2020 Dec; 610():113972. PubMed ID: 32979367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host cell protein quantification workflow using optimized standards combined with data-independent acquisition mass spectrometry.
    Hessmann S; Chery C; Sikora AS; Gervais A; Carapito C
    J Pharm Anal; 2023 May; 13(5):494-502. PubMed ID: 37305783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SWATH-MS as a strategy for CHO host cell protein identification and quantification supporting the characterization of mAb purification platforms.
    Carvalho SB; Profit L; Krishnan S; Gomes RA; Alexandre BM; Clavier S; Hoffman M; Brower K; Gomes-Alves P
    J Biotechnol; 2024 Mar; 384():1-11. PubMed ID: 38340900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host Cell Protein Profiling by Targeted and Untargeted Analysis of Data Independent Acquisition Mass Spectrometry Data with Parallel Reaction Monitoring Verification.
    Kreimer S; Gao Y; Ray S; Jin M; Tan Z; Mussa NA; Tao L; Li Z; Ivanov AR; Karger BL
    Anal Chem; 2017 May; 89(10):5294-5302. PubMed ID: 28402653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Data-Independent Acquisition Approach Combining Global HCP Profiling and Absolute Quantification of Key Impurities during Bioprocess Development.
    Husson G; Delangle A; O'Hara J; Cianferani S; Gervais A; Van Dorsselaer A; Bracewell D; Carapito C
    Anal Chem; 2018 Jan; 90(2):1241-1247. PubMed ID: 29235848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved detection of host cell proteins (HCPs) in a mammalian cell-derived antibody drug using liquid chromatography/mass spectrometry in conjunction with an HCP-enrichment strategy.
    Thompson JH; Chung WK; Zhu M; Tie L; Lu Y; Aboulaich N; Strouse R; Mo WD
    Rapid Commun Mass Spectrom; 2014 Apr; 28(8):855-60. PubMed ID: 24623688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative host cell protein analysis using two dimensional data independent LC-MS(E).
    Farrell A; Mittermayr S; Morrissey B; Mc Loughlin N; Navas Iglesias N; Marison IW; Bones J
    Anal Chem; 2015 Sep; 87(18):9186-93. PubMed ID: 26280711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to evaluate ELISA antibody coverage of host cell proteins-combining ELISA-based immunocapture and mass spectrometry.
    Pilely K; Nielsen SB; Draborg A; Henriksen ML; Hansen SWK; Skriver L; Mørtz E; Lund RR
    Biotechnol Prog; 2020 Jul; 36(4):e2983. PubMed ID: 32087048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying UHPLC-HRAM MS/MS Method to Assess Host Cell Protein Clearance during the Purification Process Development of Therapeutic mAbs.
    Kiyonami R; Melani R; Chen Y; Leon AI; Du M
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to monitor clearance of host cell proteins associated with monoclonal antibodies.
    Aboulaich N; Chung WK; Thompson JH; Larkin C; Robbins D; Zhu M
    Biotechnol Prog; 2014; 30(5):1114-24. PubMed ID: 25044920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies.
    Huang L; Wang N; Mitchell CE; Brownlee T; Maple SR; De Felippis MR
    Anal Chem; 2017 May; 89(10):5436-5444. PubMed ID: 28414239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasensitive method for profiling host cell proteins by coupling limited digestion to ProteoMiner technology.
    Zhang S; Xiao H; Li N
    Anal Biochem; 2022 Nov; 657():114901. PubMed ID: 36130653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a residual host cell protein hexosaminidase B associated with N-glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody product.
    Li X; An Y; Liao J; Xiao L; Swanson M; Martinez-Fonts K; Pavon JA; Sherer EC; Jawa V; Wang F; Gao X; Letarte S; Richardson DD
    Biotechnol Prog; 2021 May; 37(3):e3128. PubMed ID: 33476097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Quantification of a Problematic Host Cell Protein to Support Therapeutic Protein Development.
    E SY; Hu Y; Molden R; Qiu H; Li N
    J Pharm Sci; 2023 Mar; 112(3):673-679. PubMed ID: 36220394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.